# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000310158-19-000014
Filing Date
2019-02-27
Accepted
2019-02-27 16:36:42
Documents
148
Period of Report
2018-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 2018 FORM 10-K | mrk1231201810k.htm | 10-K | 4496118
2 | EXHIBIT 10.19: MERCK & CO., INC. U.S. SEPARATION BENEFITS PLAN (AS OF 1/1/19) | ex1019merckusseparationben.htm | EX-10.19 | 325789
3 | EXHIBIT 10.27: SEVERANCE AGREEMENT AND GENERAL RELEASE (SCHECHTER) | a2018form10-k_exhibit1027x.htm | EX-10.27 | 104960
4 | EXHIBIT 10.28: OFFER LETTER (ZACHARY) | a2018form10-k_ex1028xoffer.htm | EX-10.28 | 41116
5 | EXHIBIT 21: SUBSIDIARY LIST | a2018form10-k_ex21xsubsidi.htm | EX-21 | 329458
6 | EXHIBIT 23: CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ex23consentofindependentre.htm | EX-23 | 2696
7 | EXHIBIT 24.1: POWER OF ATTORNEY | ex241powerofattorneymrk123.htm | EX-24.1 | 20768
8 | EXHIBIT 24.2: CERTIFICATION OF BOARD RESOLUTION | ex242certificationofboardr.htm | EX-24.2 | 9763
9 | EXHIBIT 31.1: RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | ex311rule13a-14a15dx14acer.htm | EX-31.1 | 8501
10 | EXHIBIT 31.2: RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | ex312rule13a-14a15dx14acer.htm | EX-31.2 | 8524
11 | EXHIBIT 32.1: SECTION 1350 CERTIFICATION OF CEO | ex321section1350certificat.htm | EX-32.1 | 4783
12 | EXHIBIT 32.2: SECTION 1350 CERTIFICATION OF CFO | ex322section1350certificat.htm | EX-32.2 | 5006
19 |  | a2018form10kexhibit10_image1.jpg | GRAPHIC | 8418
20 |  | apwcsignature.jpg | GRAPHIC | 25396
21 |  | chart-c37e259168895f1daaca01.jpg | GRAPHIC | 44088
22 |  | electronicsignaturedavisa05.jpg | GRAPHIC | 31485
23 |  | g438975g32h99a01a05.jpg | GRAPHIC | 7017
24 |  | merckteallogo.jpg | GRAPHIC | 128247
| Complete submission text file | 0000310158-19-000014.txt |  | 28752912

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL INSTANCE DOCUMENT | mrk-20181231.xml | EX-101.INS | 8740113
14 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20181231.xsd | EX-101.SCH | 116370
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20181231_cal.xml | EX-101.CAL | 181807
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20181231_def.xml | EX-101.DEF | 797357
17 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20181231_lab.xml | EX-101.LAB | 1621070
18 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20181231_pre.xml | EX-101.PRE | 1091153

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06571 | Film No.: 19638252
SIC: 2834 Pharmaceutical Preparations